DEXAMETHASONE for Non-urgent Thoracic Surgery

Last updated: June 23, 2026
Sponsor: Centre Hospitalier Universitaire, Amiens
Overall Status: Trial Not Available

Phase

N/A

Condition

Cardiac Surgery

Open Heart Surgery

Spinal Surgery

Treatment

N/A

Clinical Study ID

NCT05136781
PI2021_843_0202
  • Ages > 18
  • All Genders

Study Summary

Thoracic surgery is at high risk of respiratory complications. Despite the improvement of surgical procedures such as video-thoracoscopy, respiratory complications appear in 15 to -20% of procedures. Thoracic surgery induces local pulmonary inflammation which is involved in the occurrence of post-operative respiratory failure. Similarly to the example of the acute respiratory distress syndrome, corticosteroids could reduce lung injury secondary to immunological stress. In addition, recent studies suggest that dexamethasone could lead to a reduction of respiratory complications after major non cardiothoracic surgery.

Since dexamethasone is recommended to prevent postoperative nausea and vomiting, around one in two patients receive dexamethasone during anesthetic induction. By retrospective analysis with compensation of bias by propensity score, the investigators aim to assess the effect of dexamethasone to prevent respiratory complications

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age : minimum 18 years old

  • Patients who underwent scheduled lung resection surgery

Exclusion

Exclusion Criteria:

  • absence of patient's consent

  • age under 18 years

  • pregnant women

Study Design

Study Start date:
October 26, 2021
Estimated Completion Date:
December 20, 2021

Connect with a study center

  • Centre Hospitalier Universitaire d'Amiens

    Amiens, Picardie 80000
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.